Literature DB >> 23326130

Single nucleotide polymorphisms in the CDH17 gene of colorectal carcinoma.

Ren-Yin Chen1, Juan-Juan Cao, Juan Chen, Jian-Ping Yang, Xiao-Bo Liu, Guo-Qiang Zhao, Yu-Feng Zhang.   

Abstract

AIM: To investigate the relationship between c.343A>G and c.2216A>C polymorphism sites in the CDH17 gene and colorectal carcinoma.
METHODS: Ninety-three non-consanguineous colorectal carcinoma patients admitted to the Department of Oncology at the First Affiliated Hospital of Zhengzhou University were included in this study. Ninety-three peripheral venous blood samples, of approximately one milliliter from each patient, were collected between December 2009 and August 2010. The genomic DNA of these peripheral venous blood samples were extracted and purified using a Fermentas Genomic DNA Purification Kit (Fermentas, CA) according to the manufacturer's protocol. The single nucleotide polymorphisms (SNPs) of the liver-intestine cadherin (CDH17) gene c.343A>G and c.2216A>C were determined by the polymerase chain reaction-single strand conformation polymorphism method (PCR-SSCP) in 93 peripheral venous blood samples from patients suffering with colorectal carcinoma. Typical samples that showed different migration bands in SSCP were confirmed by sequencing. Directed DNA sequencing was used to check the correctness of the genotype results from the PCR-SSCP method.
RESULTS: There was a significant association between the c.2216 A>C SNPs of the CDH17 gene and the tumor-node-metastasis (TNM) grade, as well as with lymph node status, in 93 peripheral venous blood samples from colorectal carcinoma patients. The genotype frequencies of A/C, A/A, and C/C were 12.90%, 33.33% and 53.76%, respectively. There was a significant correlation between lymph node metastasis, TNM grade, and the genotype distribution (P < 0.05). The C/C genotype raised the risk of lymph node metastasis and the TNM grade. There was a significant difference in the TNM grade and lymph node metastasis between the A/A and C/C genotypes (P = 0.003 and P = 0.013, respectively). Patients with colorectal carcinoma carrying the C allele tended to have a higher risk of lymph node metastasis and have a higher TNM grade. The difference between the TNM grades, as well as the lymph node metastasis of the two alleles, was statistically significant (P < 0.01).
CONCLUSION: The SNPs of the CDH17 gene c.2216 A>C might be clinically important in the prognosis of colorectal carcinoma.

Entities:  

Keywords:  Colorectal carcinoma; Liver-intestine cadherin; Polymerase chain reaction-single strand conformation polymorphism method; Single nucleotide polymorphisms

Mesh:

Substances:

Year:  2012        PMID: 23326130      PMCID: PMC3544027          DOI: 10.3748/wjg.v18.i48.7251

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Lentiviral-mediated miRNA against liver-intestine cadherin suppresses tumor growth and invasiveness of human gastric cancer.

Authors:  Qi-Sheng Liu; Jin Zhang; Meng Liu; Wei-Guo Dong
Journal:  Cancer Sci       Date:  2010-04-23       Impact factor: 6.716

2.  Knockdown of Li-cadherin increases metastatic behaviors of LoVo cells.

Authors:  Qiong-Fang Yu; Wei-Guo Dong; Jian-Lin Ren
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-04       Impact factor: 4.553

3.  Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.

Authors:  Reiko Ito; Naohide Oue; Kazuhiro Yoshida; Kyoko Kunimitsu; Hirofumi Nakayama; Kei Nakachi; Wataru Yasui
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

Review 4.  Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma.

Authors:  Nikki P Lee; Ronnie T P Poon; Felix H Shek; Irene O L Ng; John M Luk
Journal:  Biochim Biophys Acta       Date:  2010-05-24

5.  Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma.

Authors:  Xiao Qi Wang; John M Luk; Mercè Garcia-Barcelo; Xiaoping Miao; Pauline P Leung; David W Ho; Siu Tim Cheung; Brian Y Lam; Cindy K Cheung; Ashley S Wong; Silvana S Lau; Man Ting So; Wan Ching Yu; Qi Cai; Karen S Liu; Chee Kin Hui; George K Lau; Ronnie T P Poon; John Wong; Sheung Tat Fan
Journal:  Clin Cancer Res       Date:  2006-09-01       Impact factor: 12.531

6.  Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.

Authors:  Xiao Qi Wang; John M Luk; Pauline P Leung; Bonnie W Wong; Eric J Stanbridge; Sheung Tat Fan
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

7.  The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer.

Authors:  Jung-Myun Kwak; Byung-Wook Min; Ju-Han Lee; Jong-Sang Choi; Sun-Il Lee; Sung-Soo Park; Jin Kim; Jun-Won Um; Seon-Han Kim; Hong-Young Moon
Journal:  Dis Colon Rectum       Date:  2007-11       Impact factor: 4.585

Review 8.  Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens.

Authors:  Wataru Yasui; Naohide Oue; Kazuhiro Sentani; Naoya Sakamoto; Junichi Motoshita
Journal:  Pathol Int       Date:  2009-03       Impact factor: 2.534

9.  Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.

Authors:  E Papadopoulou; K Simopoulos; G Tripsianis; I Tentes; K Anagnostopoulos; E Sivridis; G Galazios; A Kortsaris
Journal:  Neoplasma       Date:  2007       Impact factor: 2.575

10.  LI-cadherin-mediated cell-cell adhesion does not require cytoplasmic interactions.

Authors:  B Kreft; D Berndorff; A Böttinger; S Finnemann; D Wedlich; M Hortsch; R Tauber; R Gessner
Journal:  J Cell Biol       Date:  1997-03-10       Impact factor: 10.539

View more
  1 in total

1.  A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer.

Authors:  Gururaj Shivange; Karol Urbanek; Piotr Przanowski; Justin S A Perry; James Jones; Robert Haggart; Christina Kostka; Tejal Patki; Edward Stelow; Yuliya Petrova; Danielle Llaneza; Marty Mayo; Kodi S Ravichandran; Charles N Landen; Sanchita Bhatnagar; Jogender Tushir-Singh
Journal:  Cancer Cell       Date:  2018-08-13       Impact factor: 31.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.